Entero Healthcare Solutions Limited — Updates, 09-02-2026: Press Release

Entero Healthcare acquired a 51.5% stake in Anand Chemiceutics, a diagnostic and MedTech solutions provider. This expands Entero's presence in the high-growth MedTech market. The MedTech segment is projected to contribute over INR 1,000 Cr in annualised revenue next financial year.